Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · IEX Real-Time Price · USD
0.530
-0.027 (-4.93%)
May 31, 2023, 4:00 PM EDT - Market closed
Perspective Therapeutics Market Cap
Perspective Therapeutics has a market cap or net worth of $148.47 million as of June 1, 2023. Its market cap has increased by 246.89% in one year.
Market Cap
148.47M
Enterprise Value
113.95M
1-Year Change
246.89%
Ranking
Category
Stock Price
$0.53
Market Cap Chart
Since November 10, 2005, Perspective Therapeutics's market cap has increased from $49.80M to $148.47M, an increase of 198.13%. That is a compound annual growth rate of 6.42%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 30, 2023 | 156.00M | 9.01% |
May 26, 2023 | 143.10M | 2.36% |
May 25, 2023 | 139.80M | -0.99% |
May 24, 2023 | 141.20M | -2.15% |
May 23, 2023 | 144.30M | 0.98% |
May 22, 2023 | 142.90M | 5.00% |
May 19, 2023 | 136.10M | 2.48% |
May 18, 2023 | 132.80M | 4.40% |
May 17, 2023 | 127.20M | -10.99% |
May 16, 2023 | 142.90M | -21.53% |
May 15, 2023 | 182.10M | 2.13% |
May 12, 2023 | 178.30M | -2.30% |
May 11, 2023 | 182.50M | 0.27% |
May 10, 2023 | 182.00M | -0.16% |
May 9, 2023 | 182.30M | -2.67% |
May 8, 2023 | 187.30M | 1.52% |
May 5, 2023 | 184.50M | 4.95% |
May 4, 2023 | 175.80M | 2.63% |
May 3, 2023 | 171.30M | -1.32% |
May 2, 2023 | 173.60M | 0.99% |
May 1, 2023 | 171.90M | 94.46% |
Apr 28, 2023 | 88.40M | 7.28% |
Apr 27, 2023 | 82.40M | 0.86% |
Apr 26, 2023 | 81.70M | 7.08% |
Apr 25, 2023 | 76.30M | -17.42% |
View and export this data all the way back to 2005.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Protalix BioTherapeutics, Inc. | 139.11M |
Xtant Medical Holdings, Inc. | 67.53M |
AIM ImmunoTech Inc. | 23.16M |
AgeX Therapeutics, Inc. | 17.01M |
iBio, Inc. | 12.63M |
Oragenics, Inc. | 6.18M |
cbdMD, Inc. | 5.07M |
Ampio Pharmaceuticals, Inc. | 4.53M |